Suzhou Tianma Pharma Group

Company ProTianji has an professional and experienced R&D team with a number of PhD as technical leaders with full research background(Pharmaceutical Chemistry, Organic Chemistry, Analytical Chemistry, Pharmacy, Biochemical Technology etc.). The core team has been deeply engaged in the peptide field for nearly 20 years. It is a domestic well-known peptide and small molecule drug development enterprise. In 2019, Tianji R&D lab became Jiangsu Engineering Technology Research Center. The R&D center is currently conducting technical cooperation projects with Peking University Cancer Hospital, Xijing Hospital, China Pharmaceutical University, and other domestic and foreign scientific research institutions and biomedical companies. In recent years, the annual R&D investment has increased year by years, promoting the company's sustainable innovation and development.file